- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 21, 2026 | 129.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 131.2M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 133M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $149.5M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $38.1M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $67.9M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $66M |
| Capex | Q1 2026 · Mar 31, 2026 | $176.5M |
| Capex | Q1 2026 · Mar 31, 2025 | $168M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $241.1M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $251.5M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $4.36B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $4.36B |
| Long Term Debt | Q1 2026 · Mar 31, 2025 | $4.91B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $197M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Short Term Debt | Q1 2026 · Mar 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $140.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $183.3M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $181.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.45B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $8.53B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $8.13B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $997.3M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $956.1M |
| Current Liabilities | Q1 2026 · Mar 31, 2025 | $796.9M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.2B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.15B |
| Total Liabilities | Q1 2026 · Mar 31, 2025 | $8.55B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.58B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.57B |
| Current Assets | Q1 2026 · Mar 31, 2025 | $1.93B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $16.67B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.7B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $16.71B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.26 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.97 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.27 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.97 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $135.7M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $138.3M |
| Net Income | Q1 2026 · Mar 31, 2026 | $165.5M |
| Net Income | Q1 2026 · Mar 31, 2025 | $128.9M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $265.4M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $226.4M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $422.7M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $365.3M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.76B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.63B |